This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: A Slumbering Market

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK ( TheStreet) -- The markets are just taking a nap, Jim Cramer told his "Mad Money" viewers Tuesday, and when they awaken from their slumber, they'll be heading higher.

Cramer said the markets have seen several of these rest periods, which typically come after big rallies like the one we saw after the first of the year. After each of them the markets have continued higher, he added.

That's why the markets were able to digest a host of bad news, including downgrades of American Express (AXP), Biogen Idec (BIIB), Regeneron (REGN) and United Continental (UAL), said Cramer, along with estimates cuts for Apple (AAPL) and disappointing results from Lululemon Athletica (LULU). Despite all of this bad news, a late-day rally still ensued.

Even the threat of another Congressional battle over the debt ceiling, complete with the threat of a default, government shutdown, debt downgrade or all of the above, was not enough to keep the markets down, said Cramer, because in the end, business is simply good enough to sustain the rally.

Cramer said he can't blame the analysts for jumping off the bull and getting cautious with countless estimate cuts and downgrades. After all, that's exactly what they did during all of the previous market naps as well. But as history has proven, those were the times to buy, not sell, because once the markets woke up they continued higher.

Picking Up the Pieces

Breaking up may be easy to do, but what should investors do with the pieces?

Cramer pondered that question with Abbott Laboratories (ABT), a company that spun off its pharmaceutical division on Jan. 1 as Abbvie (ABBV), a stock with a 4.7% yield, while the remaining Abbott Labs currently yields 1.7%.

Cramer first recommended Abbott, a company he owns in his charitable trust, Action Alerts PLUS , in November 2011, right after the breakup was announced. Since then, shares have risen by 24% -- raising the question of what investors should now do with the two companies they own.

Cramer said Abbott Labs, the medical products company, has 14 segments, including nutritional products, which is growing at 35% a year. The company has a lot of exposure to emerging markets, including India and China, which could account for as much as 50% of sales over the next three years.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs